Active ingredient
Bevacizumab NDC Codes
Bevacizumab is an active ingredient in 13 finished products listed with the FDA, under 7 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Labelers
- Biocon Biologics Inc., CELLTRION USA, Inc., Amneal Pharmaceuticals LLC, Pfizer Laboratories Div Pfizer Inc, Amgen, Inc, Genentech, Inc., Outlook Therapeutics, Inc.
- Strengths
- Bevacizumab 100 mg/4mL; Bevacizumab 400 mg/16mL; Bevacizumab 25 mg/mL; Bevacizumab 1.25 mg/1
- Dosage forms
- Injection, Solution, Injection
- Routes
- Intravenous, Intravascular, Intravitreal
- Drug classes (FDA established)
- Vascular Endothelial Growth Factor Inhibitor
- HCPCS / J-code
- J9035 — Injection, bevacizumab, 10 mg
- Package NDCs
- 17
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Lytenavabevacizumab-vikg | Bevacizumab 1.25 mg/1 | InjectionIntravitreal | Outlook Therapeutics, Inc. | 82491-025 | 82491-0025-10 | — |
| Jobevnebevacizumab-nwgd | Bevacizumab 25 mg/mL | InjectionIntravascular | Biocon Biologics Inc. | 83257-009 | 83257-0009-11 | — |
| Jobevnebevacizumab-nwgd | Bevacizumab 25 mg/mL | InjectionIntravascular | Biocon Biologics Inc. | 83257-010 | 83257-0010-11 | — |
| Vegzelmabevacizumab-adcd | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | CELLTRION USA, Inc. | 72606-011 | 72606-0011-0172606-0011-10 | J9035 |
| Vegzelmabevacizumab-adcd | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | CELLTRION USA, Inc. | 72606-012 | 72606-0012-0172606-0012-10 | J9035 |
| Alymsysbevacizumab-maly | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Amneal Pharmaceuticals LLC | 70121-1754 | 70121-1754-01 | J9035 |
| Alymsysbevacizumab-maly | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Amneal Pharmaceuticals LLC | 70121-1755 | 70121-1755-01 | J9035 |
| Zirabevbevacizumab-bvzr | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0315 | 00069-0315-01 | J9035 |
| Zirabevbevacizumab-bvzr | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0342 | 00069-0342-01 | J9035 |
| Mvasibevacizumab-awwb | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Amgen, Inc | 55513-206 | 55513-0206-0155513-0206-21 | J9035 |
| Mvasibevacizumab-awwb | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Amgen, Inc | 55513-207 | 55513-0207-0155513-0207-21 | J9035 |
| Avastinbevacizumab | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-060 | 50242-0060-01 | J9035 |
| Avastinbevacizumab | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-061 | 50242-0061-01 | J9035 |
Bevacizumab: common questions
- Which drugs contain Bevacizumab?
- Jobevne, Vegzelma, Alymsys, Zirabev, Mvasi, Avastin, Lytenava.
- Is there a J-code for Bevacizumab?
- Med-Code's HCPCS directory matches J9035 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.